Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
The relationship between plaque pathology and disease duration was examined in 15 patients with multiple sclerosis who died early in the course of their illness. Myelin-stained sections revealed that most plaques examined in patients who died during the first month of their illness showed evidence of ongoing myelin destruction accompanied by a loss of oligodendrocytes. Plaques containing large numbers of oligodendrocytes were not observed in these patients, but were relatively common in patients who died more than 1 month after clinical onset. Remyelination affecting more than 10% of the plaque area was observed in 3 of 82 plaques in 5 patients who died within 10 weeks of clinical onset, in 38 of 105 plaques in 5 patients who died 3 to 10 months after clinical onset, and in 19 of 92 plaques in 5 patients who died 18 months or longer after clinical onset. The study provides new evidence that both oligodendrocytes and myelin are destroyed in new lesions, that this activity ceases completely in many lesions within a few weeks, and that remyelination frequently ensues following repopulation of the plaque by oligodendrocytes. The findings suggest that new lesions normally remyelinate unless interrupted by recurrent activity and that remyelinated shadow plaques are the outcome of a single previous episode of focal demyelination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For cortical grey matter, this now indicates that oligodendrocyte recruitment and remyelination is an early phenomenon in MS lesion formation that occurs in the immediate post-phagocytic phase when foam cells are still abundant in the demyelinated lesions.56-60”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [57]
In the citing paper
“However, despite remyelination being very efficient at the early stages of the disease, this process gradually fails over time [115,116].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [115]
Citations
Cites
Handbook of clinical neurology
(1986) · Journal of Neuroimmunology · doi:10.1016/0165-5728(86)90030-5 · Cited by 1,849
Lantos, P. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.496 · Cited by 1,152
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
Payne, J. P. (1969) · British Journal of Anaesthesia · doi:10.1093/bja/41.4.356 · Cited by 600
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Self-citationRemyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
ULTRASTRUCTURAL STUDY OF REMYELINATION IN AN EXPERIMENTAL LESION IN ADULT CAT SPINAL CORD
Bunge, M. B., Bunge, R. P., & Ris, H. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.10.1.67 · Cited by 396
Proliferating bipotential glial progenitor cells in adult rat optic nerve
ffrench-Constant, C., & Raff, M. C. (1986) · Nature · doi:10.1038/319499a0 · Cited by 385
Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
Pathology of the Nervous System
Krigman, M. R. (1969) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1969.03160150057026 · Cited by 286
Research works printed but not linked: 3
- Schlesinger H, 1909, Zur Frage der akuten multiplen Sklerose und der Enzephalomyelitis disseminata im Kindesalter, Arch Neurol Inst, Wien, 17, 410
- Greenfield JG, 1958, Neuropathology, 441
- Jacob H, 1969, Tissue process in multiple sclerosis and parainfectious and post‐vaccinal encephalomyelitis, Int Arch Allergy Appl Immunol, 36, 22
Cited by
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Self-citationThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Lassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
“Remyelination can be observed in lesions with ongoing demyelinating activity (Prineas et al., 1993; Raine and Wu, 1993).”
BackgroundWhy does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn917 · Cited by 837
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
“From these studies it was concluded that remyelination transiently occurs during the acute and early relapsing stage of the disease, being sparse or absent in patients with late chronic disease (Prineas et al., 1993a; Ozawa et al., 1994; Frohman et al., 2006).”
BackgroundInfluentialMagnetization transfer ratio and myelin in postmortem multiple sclerosis brain
Schmierer, K., Scaravilli, F., Altmann, D. R., Barker, G. J., & Miller, D. H. (2004) · Annals of Neurology · doi:10.1002/ana.20202 · Cited by 776
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
An updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684
“It has been suggested to stimulate remyelination (Butovsky et al., 2006; Miron et al., 2013) and early stages of remyelination within multiple sclerosis lesions are mainly seen in the core of active lesions (Raine et al., 1981; Prineas et al., 1993; Raine, 2017).”
BackgroundInduction of myelination in the central nervous system by electrical activity
Demerens, C., Stankoff, B., Logak, M., Anglade, P., Allinquant, B., Couraud, F., Zalc, B., & Lubetzki, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9887 · Cited by 678
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
The role of magnetic resonance techniques in understanding and managing multiple sclerosis
Miller, D. (1998) · Brain · doi:10.1093/brain/121.1.3 · Cited by 556
Diffusion tensor magnetic resonance imaging in multiple sclerosis
Filippi, M., Cercignani, M., Inglese, M., Horsfield, M. A., & Comi, G. (2001) · Neurology · doi:10.1212/wnl.56.3.304 · Cited by 546
Endogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544
The role of nitric oxide in multiple sclerosis
Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 531
Immunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Self-citationAgeing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Remyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
Remyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411
Filippi, M., Rocca, M. A., Martino, G., Horsfield, M. A., & Comi, G. (1998) · Annals of Neurology · doi:10.1002/ana.410430616 · Cited by 395
Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions
Henderson, A. P. D., Barnett, M. H., Parratt, J. D. E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21800 · Cited by 387
Self-citationKeirstead, H. S., Levine, J. M., & Blakemore, W. F. (1998) · Glia · doi:10.1002/(sici)1098-1136(199802)22:2<161::aid-glia7>3.0.co;2-a · Cited by 345
Keirstead, H. S., Levine, J. M., & Blakemore, W. F. (1998) · Glia · doi:10.1002/(sici)1098-1136(199802)22:2<180::aid-glia9>3.0.co;2-b · Cited by 345
Smith, K. J., & McDonald, W. I. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0510 · Cited by 340
THE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS
Ludwin, S. K. (2000) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00665-3 · Cited by 329
Keegan, B. M., & Noseworthy, J. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103909 · Cited by 319
Remyelination can be extensive in multiple sclerosis despite a long disease course
Patani, R., Balaratnam, M., Vora, A., & Reynolds, R. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00805.x · Cited by 318
Extensive cortical remyelination in patients with chronic multiple sclerosis
Albert, M., Antel, J., Brück, W., & Stadelmann, C. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00043.x · Cited by 314
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
Neuropathology in multiple sclerosis: new concepts
Lassmann, H. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400301 · Cited by 306
Charles, P., Hernandez, M. P., Stankoff, B., Aigrot, M. S., Colin, C., Rougon, G., Zalc, B., & Lubetzki, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100076197 · Cited by 306
Pathology of multiple sclerosis and related inflammatory demyelinating diseases
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 303
High field MRI correlates of myelin content and axonal density in multiple sclerosis
Mottershead, J. P., Schmierer, K., Clemence, M., Thornton, J. S., Scaravilli, F., Barker, G. J., Tofts, P. S., Newcombe, J., Cuzner, M. L., Ordidge, R. J., et al. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0192-3 · Cited by 296
Scolding, N. (1998) · Brain · doi:10.1093/brain/121.12.2221 · Cited by 293
Boyd, A., Zhang, H., & Williams, A. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1112-y · Cited by 287
In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation
Bulte, J. W. M., Duncan, I. D., & Frank, J. A. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200208000-00001 · Cited by 288
“In multiple sclerosis (MS), the most prevalent acquired myelin disease, remyelination has also been observed (Prineas et al., 1993; Raine and Scheinberg, 1981).”
BackgroundThe Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion
Raine, C. S. (1994) · Annals of Neurology · doi:10.1002/ana.410360716 · Cited by 285
Remyelination therapies: a new direction and challenge in multiple sclerosis
Plemel, J. R., Liu, W.-Q., & Yong, V. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.115 · Cited by 281
MULTIPLE SCLEROSIS AND THE UROLOGIST
LITWILLER, S. E., FROHMAN, E. M., & ZIMMERN, P. E. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61760-9 · Cited by 282
Progress in determining the causes and treatment of multiple sclerosis
Noseworthy, J. H. (1999) · Nature · doi:10.1038/399a040 · Cited by 278
van Waesberghe, J. H., van Walderveen, M. A. A., Castelijns, J. A., Scheltens, P., Nijeholt, G. J. L. À., Polman, C. H., & Barkhof, F. (1998) · American Journal of Neuroradiology · Cited by 311
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276
Ben‐Hur, T., Einstein, O., Mizrachi‐Kol, R., Ben‐Menachem, O., Reinhartz, E., Karussis, D., & Abramsky, O. (2003) · Glia · doi:10.1002/glia.10159 · Cited by 272
“Central to this problem is the very limited capacity of the brain to remyelinate MS lesions by the endogenous pool of regenerating cells (Prineas et al., 1993; McDonald, 1994).”
BackgroundLarsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G., & Yong, V. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11127.2003 · Cited by 260
“The CNS does attempt recovery from such insults, and remyelination occurs in MS lesions, albeit to a limited extent (Prineas et al., 1993; Chang et al., 2002).”
BackgroundFard, M. K., van der Meer, F., Sánchez, P., Cantuti-Castelvetri, L., Mandad, S., Jäkel, S., Fornasiero, E. F., Schmitt, S., Ehrlich, M., Starost, L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7816 · Cited by 249
Oligodendrocyte lineage cells and depression
Zhou, B., Zhu, Z., Ransom, B. R., & Tong, X. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00930-0 · Cited by 242
Cells of the oligodendroglial lineage, myelination, and remyelination
Miron, V. E., Kuhlmann, T., & Antel, J. P. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.010 · Cited by 242
In vivo proliferation of oligodendrocyte progenitors expressing PDGF?R during early remyelination
Redwine, J. M., & Armstrong, R. C. (1998) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19981115)37:3<429::aid-neu8>3.0.co;2-n · Cited by 243
Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis
Wolswijk, G. (2000) · Brain · doi:10.1093/brain/123.1.105 · Cited by 237
“…does appear to be a prominent feature in lesions that develop during the early course of multiple sclerosis (Lassmann, 1983; Prineas, 1985; Prineas et al., 1993a, b; Raine and Wu, 1993; Brück et al., 1994; Ozawa et al., 1994), although the extent to which this occurs may depend on…”
BackgroundThe contribution of demyelination to axonal loss in multiple sclerosis
DeLuca, G. C. (2006) · Brain · doi:10.1093/brain/awl074 · Cited by 231
“The relative paucity of remyelination in the spinal cord lesions in our cohort contrasts the degree of remyelination reported to occur in the cerebral hemispheres (Prineas et al., 1993).”
BackgroundRobinson, S., Tani, M., Strieter, R. M., Ransohoff, R. M., & Miller, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10457.1998 · Cited by 229
“Expression of GRO-␣ may also regulate local elevated levels of oligodendrocyte precursor proliferation in the adult CNS. Enhanced oligodendrocyte precursor proliferation is seen adjacent to demyelinating lesions (Raine et al., 1988; Prineas et al., 1993).”
BackgroundPathogenesis of multiple sclerosis
ffrench-Constant, C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91118-5 · Cited by 226
Hinks, G. L., & Franklin, R. J. M. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0771 · Cited by 219
Behrendt, G., Baer, K., Buffo, A., Curtis, M. A., Faull, R. L., Rees, M. I., Götz, M., & Dimou, L. (2013) · Glia · doi:10.1002/glia.22432 · Cited by 219
“It has been shown that large diameter remyelinated fibers, in contrast to small diameter axons, can be recognized by thinner and less compacted myelin sheaths (Blakemore, 1974; Prineas et al., 1993).”
BackgroundPurification and Characterization of Adult Oligodendrocyte Precursor Cells from the Rat Optic Nerve
Shi, J., Marinovich, A., & Barres, B. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04627.1998 · Cited by 219
Cortical remyelination: A new target for repair therapies in multiple sclerosis
Chang, A., Staugaitis, S. M., Dutta, R., Batt, C. E., Easley, K. E., Chomyk, A. M., Yong, V. W., Fox, R. J., Kidd, G. J., & Trapp, B. D. (2012) · Annals of Neurology · doi:10.1002/ana.23693 · Cited by 216
Oligodendrocytes in the early course of multiple sclerosis
Brück, W., Schmied, M., Suchanek, G., Brück, Y., Breitschopf, H., Poser, S., Piddlesden, S., & Lassmann, H. (1994) · Annals of Neurology · doi:10.1002/ana.410350111 · Cited by 216
Bitsch, A., Kuhlmann, T., Stadelmann, C., Lassmann, H., Lucchinetti, C., & Brück, W. (2001) · Annals of Neurology · doi:10.1002/ana.1053 · Cited by 216
Yao, D. L., Liu, X., Hudson, L. D., & Webster, H. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6190 · Cited by 215
Conduction in Segmentally Demyelinated Mammalian Central Axons
Felts, P. A., Baker, T. A., & Smith, K. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07267.1997 · Cited by 211
“It is now clear that some demyelinated lesions are partially repaired by remyelination and that this phenomenon can be quite common and extensive in early lesions (Prineas et al., 1993a).”
BackgroundRemyelination in multiple sclerosis
Brück, W., Kuhlmann, T., & Stadelmann, C. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00191-0 · Cited by 200
Sugawa, M., Sakurai, Y., Ishikawa-Ieda, Y., Suzuki, H., & Asou, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00161-x · Cited by 197
CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis
Omari, K. M., John, G. R., Sealfon, S. C., & Raine, C. S. (2005) · Brain · doi:10.1093/brain/awh479 · Cited by 196
“Despite the presence of OPCs (Scolding et al., 1998; Chang et al., 2000; Maeda et al., 2001; Wolswijk, 2002), remyelination in multiple sclerosis is usually limited in extent (Prineas et al., 1993; Raine and Wu, 1993; Franklin, 2002).”
BackgroundMechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
“This finding is surprising since evidence for initial stages of remyelination is frequently seen in active lesions in particular in patients at the early (relapsing) stage of the disease and in lesions which contain high numbers of macrophages (Raine et al., 1981, Prineas et al., 1993a).”
BackgroundRemyelination in multiple sclerosis
Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191
Chen, J. T., Collins, D. L., Atkins, H. L., Freedman, M. S., Arnold, D. L., & the Canadian MS/BMT Study Group (2008) · Annals of Neurology · doi:10.1002/ana.21302 · Cited by 190
Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions
Traiffort, E., Kassoussi, A., Zahaf, A., & Laouarem, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00079 · Cited by 187
“…in the spontaneous regenerative process of remyelination that can occur with remarkable efficiency, not only in experimental models of demyelination but also in humans suffering from MS (Prineas et al., 1993; Patrikios et al., 2006; Patani et al., 2007; Franklin and Ffrench-Constant, 2017).”
BackgroundCadavid, D., Mellion, M., Hupperts, R., Edwards, K. R., Calabresi, P. A., Drulović, J., Giovannoni, G., Hartung, H.-P., Arnold, D. L., Fisher, E., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30137-1 · Cited by 185
Sedel, F., Bernard, D., Mock, D. M., & Tourbah, A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.028 · Cited by 184
“Extensive regenerative remyelination occurs in some patients with early MS but is typically reduced as the disease progresses (Goldschmidt et al., 2009; Miron et al., 2011; Prineas et al., 1993).”
CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities
Franklin, R. J. M., & Simons, M. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.023 · Cited by 184
Armstrong, R. C., Le, T. Q., Frost, E. E., Borke, R. C., & Vana, A. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08574.2002 · Cited by 178
“Remyelination brings about limited myelin repair of MS lesions over time (Prineas et al., 1993; Raine and Wu, 1993).”
BackgroundDi Bello, I. C., Dawson, M. R. L., Levine, J. M., & Reynolds, R. (1999) · Journal of Neurocytology · doi:10.1023/a:1007069815302 · Cited by 179
“In the most common human demyelinating disease, multiple sclerosis (MS), repeated episodes of myelin destruction result in the formation of lesions that remain chronically demyelinated (Prineas et al., 1993a).”
BackgroundThe response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS
Reynolds, R., Dawson, M., Papadopoulos, D., Polito, A., di Bello, I. C., Pham-Dinh, D., & Levine, J. (2002) · Journal of Neurocytology · doi:10.1023/a:1025747832215 · Cited by 175
Stem cells for the treatment of spinal cord injury
Coutts, M., & Keirstead, H. S. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.09.002 · Cited by 177
Neurodegeneration in multiple sclerosis
Mey, G. M., Mahajan, K. R., & DeSilva, T. M. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1583 · Cited by 169
“Additionally, those with progressive MS are less likely to experience remyelinated lesions, also referred to as “shadow plaques,” than those with relapsing MS (Frischer et al., 2015; Goldschmidt et al., 2009; Patrikios et al., 2006; Prineas et al., 1993).”
BackgroundGray and white matter volume changes in early RRMS: A 2-year longitudinal study
Tiberio, M., Chard, D. T., Altmann, D. R., Davies, G., Griffin, C. M., Rashid, W., Sastre-Garriga, J., Thompson, A. J., & Miller, D. H. (2005) · Neurology · doi:10.1212/01.wnl.0000154526.22878.30 · Cited by 168
Long-term remyelination after optic neuritis
Brusa, A., Jones, S. J., & Plant, G. T. (2001) · Brain · doi:10.1093/brain/124.3.468 · Cited by 165
“The demyelination of CNS axons which occurs in multiple sclerosis was once thought to be irreversible, but there is increasing neuropathological evidence that remyelination does occur for a period of time after the demyelinating episode (Prineas et al., 1984, 1987, 1993a, b).”
BackgroundThe biology of CNS remyelination: The key to therapeutic advances
Franklin, R. J. M., & Kotter, M. R. (2008) · Journal of Neurology · doi:10.1007/s00415-008-1004-6 · Cited by 160
Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions
Mews, I., Bergmann, M., Bunkowski, S., Gullotta, F., & Brück, W. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400203 · Cited by 160
Promoting remyelination in multiple sclerosis
Cunniffe, N., & Coles, A. (2021) · Journal of Neurology · doi:10.1007/s00415-019-09421-x · Cited by 159
Advanced MRI and staging of multiple sclerosis lesions
Absinta, M., Sati, P., & Reich, D. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.59 · Cited by 169
In vivo evaluation of remyelination in rat brain by magnetization transfer imaging
Deloire-Grassin, M., Brochet, B., Quesson, B., Delalande, C., Dousset, V., Canioni, P., & Petry, K. G. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00331-2 · Cited by 149
Oligodendrocytes and the early multiple sclerosis lesion
Prineas, J. W., & Parratt, J. D. E. (2012) · Annals of Neurology · doi:10.1002/ana.23634 · Cited by 149
Self-citationMyelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
Podbielska, M., Banik, N. L., Kurowska, E., & Hogan, E. (2013) · Brain Sciences · doi:10.3390/brainsci3031282 · Cited by 194
Mature microglia resemble immature antigen-presenting cells
Carson, M. J., Reilly, C. R., Sutcliffe, J. G., & Lo, D. (1998) · Glia · doi:10.1002/(sici)1098-1136(199801)22:1<72::aid-glia7>3.0.co;2-a · Cited by 337
Zhao, C., Li, W.-W., & Franklin, R. J. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.008 · Cited by 142
Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis
Garay, L. I., Deniselle, M. C. G., Lima, A. E., Roig, P., & Nicola, A. F. D. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.040 · Cited by 143
Raine, C. S. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00073-8 · Cited by 153
Meningeal inflammation and cortical demyelination in acute multiple sclerosis
Bevan, R. J., Evans, R., Griffiths, L., Watkins, L. M., Rees, M. I., Magliozzi, R., Allen, I. V., McDonnell, G. V., Kee, R., Naughton, M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25365 · Cited by 160
Archer, D. R., Cuddon, P. A., Lipsitz, D., & Duncan, I. D. (1997) · Nature Medicine · doi:10.1038/nm0197-54 · Cited by 138
Oxidative damage to DNA in plaques of MS brains
Vladimirova, O. V., O'Connor, J. J., Cahill, A., Alder, H., Butunoi, C., & Kálmán, B. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400503 · Cited by 147
Role for CXCR2 and CXCL1 on glia in multiple sclerosis
Omari, K. M., John, G. R., Lango, R., & Raine, C. S. (2005) · Glia · doi:10.1002/glia.20246 · Cited by 148
“Paradoxically, early and active MS plaques may show an increased number of oligodendrocytes and some remyelination (Raine et al., 1981; Prineas et al., 1989, 1993; Raine and Wu, 1993), but these diminish as lesions age.”
BackgroundMeasuring Myelin Repair and Axonal Loss with Diffusion Tensor Imaging
Fox, R. J., Cronin, T., Lin, J. Y., Wang, X., Sakaie, K., Ontaneda, D., Mahmoud, S. Y., Lowe, M. J., & Phillips, M. D. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2238 · Cited by 147
Metadata
- Authors
- Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐.
- Affiliations
- East Orange VA Medical Center (US)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Prineas, J. W.
- ORCID
- Prineas, J. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-02
- Volume
- 33
- Issue
- 2
- Pages
- 137-151
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2024751716
- Cited by
- 574
- References
- 46
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 14 · 2019: 19 · 2018: 14 · 2017: 12 · 2016: 10 · 2015: 14 · 2014: 18 · 2013: 13 · 2012: 16
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- multiple sclerosis, remyelination, demyelination, oligodendrocytes, myelin destruction, disease duration, early-onset multiple sclerosis
- MeSH terms
- Adolescent, Adult, Aged, Axons, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Myelin Sheath, Nerve Regeneration, Oligodendroglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.